Valuation: Orion Oyj

Market Cap 12.29B 13.82B 11.39B 10.36B 19.55B 1,312B 19.87B 137B 53.68B 685B 51.88B 50.78B 2,183B P/E 2026 *
21.6x
P/E 2027 * 18.5x
Enterprise Value 12.19B 13.72B 11.3B 10.28B 19.4B 1,302B 19.72B 136B 53.26B 679B 51.48B 50.39B 2,166B EV / Sales 2026 *
5.79x
EV / Sales 2027 * 5.02x
Free-Float
90.5%
Yield 2026 *
2.24%
Yield 2027 * 2.47%
1 day+1.50%
1 week+10.18%
Current month+5.54%
1 month+7.41%
3 months+13.31%
6 months+16.86%
Current year+37.78%
1 week 79.4
Extreme 79.4
87.7
1 month 78.75
Extreme 78.75
87.7
Current year 62.7
Extreme 62.7
87.7
1 year 56.5
Extreme 56.5
87.7
3 years 31.86
Extreme 31.86
87.7
5 years 31.86
Extreme 31.86
87.7
10 years 22.57
Extreme 22.57
87.7
Manager TitleAgeSince
Chief Executive Officer 59 2022-10-31
Director of Finance/CFO 50 2024-04-30
Chief Operating Officer 46 2021-12-31
Director TitleAgeSince
Director/Board Member 63 2017-03-21
Director/Board Member 65 2017-03-21
Director/Board Member 66 2020-05-05
Date Insider Type Main position Quantity % Market Cap. Importance
8/8/25 Sell

Chief Operating Officer

4,000 0.0122%
8/4/25 Sell

Executive/Senior Manager

71 0.0002%
8/4/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+10.18%+30.60%+127.20% 13.82B
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average -0.01%+4.27%+34.02%+67.85% 395.47B
Weighted average by Cap. +0.14%+3.85%+39.31%+72.02%

Financials

2026 *2027 *
Net sales 2.1B 2.37B 1.95B 1.77B 3.35B 225B 3.4B 23.45B 9.19B 117B 8.89B 8.7B 374B 2.38B 2.67B 2.2B 2.01B 3.78B 254B 3.84B 26.49B 10.39B 132B 10.04B 9.83B 422B
Net income 571M 642M 529M 481M 908M 60.93B 923M 6.36B 2.49B 31.8B 2.41B 2.36B 101B 669M 752M 620M 564M 1.06B 71.38B 1.08B 7.45B 2.92B 37.25B 2.82B 2.76B 119B
Net Debt -94.56M -106M -87.64M -79.74M -150M -10.1B -153M -1.05B -413M -5.27B -399M -391M -16.8B -345M -388M -320M -291M -550M -36.87B -558M -3.85B -1.51B -19.24B -1.46B -1.43B -61.33B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
26-10-16 €87.70 +1.50% 252,768
26-10-15 €86.40 +0.52% 235,433
26-10-14 €85.95 +3.87% 288,318
26-10-13 €82.75 +0.18% 137,382
26-10-12 €82.60 +3.77% 119,141
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
87.70EUR
Average target price
77.33EUR
Spread / Average Target
-11.82%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Orion Oyj
  1. Stock Market
  2. Stocks
  3. ORNBV Stock